Colombia vs Eswatini, Kingdom of: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Colombia
89.0%
in 2025
Eswatini, Kingdom of
90.0%
in 2025
Colombia rank
70th
Eswatini, Kingdom of rank
68th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Colombia
- Eswatini, Kingdom of
How they compare
Eswatini, Kingdom of currently reports 90.0% against 89.0% in Colombia, a difference of 1.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Eswatini, Kingdom of ahead.
Colombia ranks 70th and Eswatini, Kingdom of ranks 68th of 192 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Eswatini, Kingdom of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 78.6% | 50.9% | 27.7% | Colombia |
| 2020s | 88.0% | 79.3% | 8.7% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Colombia or Eswatini, Kingdom of?
- Eswatini, Kingdom of, at 90.0% against 89.0% in Colombia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Colombia and Eswatini, Kingdom of?
- 1.0%, with Eswatini, Kingdom of ahead.
- How many years of comparable data are there for Colombia and Eswatini, Kingdom of?
- 18 years are reported by both, from 2008 to 2025.
- How do Colombia and Eswatini, Kingdom of rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Colombia ranks 70th and Eswatini, Kingdom of ranks 68th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.